Koninklijke Philips NV vs Snap Inc — how do they compare? Koninklijke Philips NV trades at $24.22 (market cap $23.52B), while Snap Inc trades at $6.24 (market cap $9.83B). The key difference: Koninklijke Philips NV is far larger — about 2.4× Snap Inc's market cap, and Koninklijke Philips NV pays a 4.17% dividend while Snap Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Koninklijke Philips NV for 84 Days and Snap Inc for 68 Days on average.
| PHG | SNAP | |
|---|---|---|
Market Cap | $23.52B | $9.83B |
Volume | 1,635,069 | 28,532,342 |
Sector | Health | Media |
52-Week High | $32.91 | $9.09 |
52-Week Low | $23.81 | $3.93 |
Typical Hold Time | 84 Days | 68 Days |
Enterprise Value | $29.87B | $11.39B |
Dividend Yield | 4.17% | — |
Signals from Pluang's Aura AI — not financial advice
PHG trades at $24.24, up 0.62% today, amid a bearish technical signal from moving averages. The company has beaten EPS estimates for three consecutive quarters, with Q3 2026 results pending. Recent financials show a return to profitability in 2025 with net income of $895 million, while cash flow from operations remains positive at $1.17 billion. Key developments include new product launches in healthcare imaging and a $33.7 million ARPA-H award for AI-enabled stroke care.
The outlook is mixed: strong earnings momentum and solid profitability metrics support upside, but technical weakness and a high 'Hold' analyst consensus suggest near-term caution. Risks include competitive pressures and debt levels, though institutional buying activity indicates underlying confidence.
Snap Inc. (SNAP) trades at $6.235, up 7.31% with bullish technical signals and strong institutional interest. The company shows improving fundamentals with revenue growth from $5.4B to $5.9B (2024-2025) and narrowing losses. Recent AI partnerships with Nvidia and Salesforce for SPECS glasses highlight innovation efforts. Operating cash flow improved to $656M in 2025, though net income remains negative at -$460M.
While Snap demonstrates operational momentum and analyst support (38% buy ratings), significant risks persist including regulatory pressures, intense competition, and continued profitability challenges. The stock's current valuation at 1.55x sales appears reasonable given growth trajectory, but investors should weigh improving fundamentals against persistent net losses and high debt levels.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →Snap, which refers to itself as a camera company, has one of the most popular social networking apps, Snapchat, in developed regions such as North America and Europe. The firm has approximately 158 million daily active users. Snap generates nearly all of its revenue from advertising with 88% coming from the U.S. The firm is headquartered in Venice, California.
Read more on SNAP →